HK1160396A1 - Circulation of components during homogenization of emulsions - Google Patents

Circulation of components during homogenization of emulsions

Info

Publication number
HK1160396A1
HK1160396A1 HK12100892.5A HK12100892A HK1160396A1 HK 1160396 A1 HK1160396 A1 HK 1160396A1 HK 12100892 A HK12100892 A HK 12100892A HK 1160396 A1 HK1160396 A1 HK 1160396A1
Authority
HK
Hong Kong
Prior art keywords
circulation
emulsions
container
components during
during homogenization
Prior art date
Application number
HK12100892.5A
Other languages
English (en)
Inventor
Harald Rueckl
Hanno Scheffczik
Barbara Santry
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43923723&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1160396(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1160396A1 publication Critical patent/HK1160396A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/44—Mixers in which the components are pressed through slits
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
    • B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Edible Oils And Fats (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
HK12100892.5A 2009-12-03 2012-02-01 Circulation of components during homogenization of emulsions HK1160396A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28351809P 2009-12-03 2009-12-03

Publications (1)

Publication Number Publication Date
HK1160396A1 true HK1160396A1 (en) 2012-08-17

Family

ID=43923723

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12100892.5A HK1160396A1 (en) 2009-12-03 2012-02-01 Circulation of components during homogenization of emulsions
HK13102698.6A HK1175404A1 (zh) 2009-12-03 2013-03-05 乳劑均質化和微流化期間的組分流通

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13102698.6A HK1175404A1 (zh) 2009-12-03 2013-03-05 乳劑均質化和微流化期間的組分流通

Country Status (23)

Country Link
US (6) USRE46441E1 (zh)
EP (3) EP2356983B1 (zh)
JP (2) JP5820390B2 (zh)
KR (1) KR101523215B1 (zh)
CN (2) CN105055311A (zh)
AU (1) AU2010325752B2 (zh)
BR (1) BR112012013427B8 (zh)
CA (1) CA2782511C (zh)
DK (1) DK2356983T3 (zh)
EA (1) EA024770B1 (zh)
ES (2) ES2573710T3 (zh)
HK (2) HK1160396A1 (zh)
HR (1) HRP20130398T1 (zh)
IL (1) IL219984B (zh)
MX (3) MX360299B (zh)
NZ (1) NZ600323A (zh)
PL (1) PL2356983T3 (zh)
PT (1) PT2356983E (zh)
RS (1) RS52748B (zh)
SG (2) SG181096A1 (zh)
SI (2) SI2506834T1 (zh)
SM (1) SMT201300044B (zh)
WO (1) WO2011067673A2 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
US10842867B2 (en) * 2005-11-04 2020-11-24 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
ES2608841T3 (es) 2009-02-10 2017-04-17 Seqirus UK Limited Vacunas contra la gripe con cantidades reducidas de escualeno
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CL2012001399A1 (es) * 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
BR112012013427B8 (pt) 2009-12-03 2021-05-25 Novartis Ag circulação dos componentes durante a homogeneização de emulsões
AU2010325748B2 (en) 2009-12-03 2014-04-17 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
PL3489211T3 (pl) 2010-05-12 2020-12-14 Novartis Ag Ulepszone sposoby otrzymywania skwalenu
RU2014140521A (ru) 2012-03-08 2016-04-27 Новартис Аг Адъювантные составы бустерных вакцин
EP2892553A1 (en) 2012-09-06 2015-07-15 Novartis AG Combination vaccines with serogroup b meningococcus and d/t/p
SG11201502599TA (en) 2012-10-12 2015-05-28 Glaxosmithkline Biolog Sa Non-cross-linked acellular pertussis antigens for use in combination vaccines
EP2934574A1 (en) 2012-12-18 2015-10-28 GlaxoSmithKline Biologicals SA Conjugates for protecting against diphtheria and/or tetanus
RU2550253C2 (ru) * 2013-06-25 2015-05-10 Татьяна Владимировна Шленская Устройство для получения гомогенного молочного продукта и способ гидратации полярных молекул аминокислот молочных белков в процессе приготовления гомогенного молочного продукта
US9127542B2 (en) 2014-01-28 2015-09-08 Lawrence O. Price Subterranean well treatment process
WO2016046799A1 (en) 2014-09-26 2016-03-31 Seqirus UK Limited Vaccination of immunocompromised subjects
KR20230154072A (ko) 2014-09-26 2023-11-07 세퀴러스 유케이 리미티드 면역손상된 대상체의 백신 접종
EP3511020B1 (en) 2014-12-02 2021-01-20 Novartis AG Manufacture of surfactant-containing compositions
WO2017214497A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
IT201800007790A1 (it) * 2018-08-02 2020-02-02 Gea Mech Equipment Italia Spa Omogeneizzatore ad alta pressione
CN111999489A (zh) * 2020-09-21 2020-11-27 上海科华生物工程股份有限公司 用于连续生产胶乳免疫比浊法的过滤分散设备和方法
WO2022112191A1 (en) * 2020-11-25 2022-06-02 Univerza V Ljubljani Liquid decontamination system comprising a cavitation device and method of decontamination of a liquid

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1876979U (de) 1963-06-14 1963-08-01 Rehau Plastiks Sickerleitungsrohr.
CA951238A (en) 1970-06-10 1974-07-16 Ralph R. Calaceto Abrasion resistant venturi scrubbers
US4060082A (en) 1976-08-16 1977-11-29 Mpl, Inc. Dual-ingredient medication dispenser
US4340482A (en) 1978-02-21 1982-07-20 Millipore Corporation Process for grafting amino acid molecules onto preformed polymer surfaces and products prepared thereby
US4473474A (en) 1980-10-27 1984-09-25 Amf Inc. Charge modified microporous membrane, process for charge modifying said membrane and process for filtration of fluid
US4673504A (en) 1980-10-27 1987-06-16 Cuno Inc. Charge modified microporous membrane
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4432875A (en) 1981-05-29 1984-02-21 Brunswick Corporation Semi-permeable membranes and processes for making the same
US4473475A (en) 1981-05-29 1984-09-25 Amf Inc. Charge modified microporous membrane, process for charge modifying said membrane, and process for filtration of fluids
US4413074A (en) 1982-01-25 1983-11-01 Brunswick Corporation Hydrophilic surfaces and process for making the same
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US4705753A (en) 1984-06-08 1987-11-10 Gregor Harry P Biologically active acrylonitrile-based copolymeric membrane
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
US4794002A (en) 1985-11-01 1988-12-27 Monsanto Company Modified polymeric surfaces and process for preparing same
US4964990A (en) 1987-05-20 1990-10-23 Gelman Sciences, Inc. Filtration membranes and method of making the same
US4943374A (en) 1988-04-21 1990-07-24 Gessner & Co., Gmbh Use of a microporous membrane constructed of polyether sulfon and hydrophilization agent for the filtration of beer
AU4529289A (en) 1988-10-17 1990-05-14 Sepracor, Inc. Process for the covalent surface modification of hydrophobic polymers and articles made therefrom
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
ES2135406T3 (es) * 1991-05-08 1999-11-01 Schweiz Serum & Impfinst Virosomas de la influenza reconstituidos inmunoestimulantes e inmunopotencializadores y vacunas que los contienen.
JPH0614756Y2 (ja) 1991-06-26 1994-04-20 株式会社アルテ 組み立て式の２室式容器兼用注射器
US5178765A (en) 1991-09-18 1993-01-12 Gelman Sciences Inc. Hydrophilic membranes prepared from polyethersulfone/poly-2-oxazoline/polyvinylpyrrolidone blend
SG49746A1 (en) 1992-08-28 1998-06-15 Pharmos Corp Submicron emulsions as ocular drug delivery vehicles
US5277812A (en) 1993-02-12 1994-01-11 Gelman Sciences Inc. Inter-penetrating network charge modified microporous membrane
US5531893A (en) 1993-02-12 1996-07-02 Gelman Sciences Inc. Inter-penetrating network charge modified microporous membrane
US6645463B1 (en) 1994-05-16 2003-11-11 The Board Of Regents Of The University Of Michigan Blood-pool selective carrier for lipophilic imaging agents
DE69528062T2 (de) 1994-06-20 2003-04-30 Nippon Shinyaku Co Ltd Verfahren zum herstellen von emulsionen aus einem emulgator
US5487965A (en) 1994-09-06 1996-01-30 Xerox Corporation Processes for the preparation of developer compositions
US5496284A (en) 1994-09-27 1996-03-05 Waldenburg; Ottfried Dual-chamber syringe & method
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
DE19542499A1 (de) 1995-11-15 1997-05-22 Bayer Ag Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
WO1998001174A1 (fr) 1996-07-05 1998-01-15 Debiotech S.A. Seringue a chambre double permettant le melange de deux produits avant leur injection
US6168718B1 (en) 1996-11-08 2001-01-02 Pall Corporation Method for purifying blood plasma and apparatus suitable therefor
JP4451931B2 (ja) 1996-11-12 2010-04-14 ホアットマン，インコーポレーテッド 親水性のポリマー状の相転換メンブレン
US5971953A (en) 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
WO1999017820A1 (en) 1997-10-03 1999-04-15 Texas Pharmaceuticals, Inc. Improved dual chamber syringe apparatus
US6039872A (en) 1997-10-27 2000-03-21 Pall Corporation Hydrophilic membrane
WO1999050189A1 (fr) 1998-03-30 1999-10-07 Ebara Corporation Procede et dispositif de traitement des eaux riches en manganese
GB9808689D0 (en) 1998-04-23 1998-06-24 Kalsep Ltd Improved membrane
JP3995830B2 (ja) 1999-01-13 2007-10-24 富士フイルム株式会社 熱現像画像記録材料
US6193077B1 (en) 1999-02-08 2001-02-27 Osmonics, Inc. Non-cracking hydrophilic polyethersulfone membranes
AU2875700A (en) 1999-02-26 2000-09-14 Chiron Corporation Microemulsions with adsorbed macromoelecules and microparticles
KR100310234B1 (ko) 1999-08-20 2001-11-14 안복현 반도체 소자 ｃｍｐ용 금속산화물 슬러리의 제조방법
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
DE10059430A1 (de) 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20060148776A1 (en) 2003-03-13 2006-07-06 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
ES2398235T3 (es) 2003-04-04 2013-03-14 Pah Usa 15 Llc Emulsiones de aceite en agua microfluidizadas y composiciones de vacunas
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
CA2528095C (en) 2003-06-04 2014-10-14 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
KR20120091378A (ko) 2004-03-23 2012-08-17 노파르티스 아게 제약 조성물
CN1933862A (zh) 2004-03-23 2007-03-21 尼普洛株式会社 预充式注射器
GB0406515D0 (en) * 2004-03-23 2004-04-28 Novartis Ag Organic compounds
SI1742659T1 (sl) 2004-04-05 2013-07-31 Zoetis P Llc Mikrofluidizirane emulzije olja v vodi in sestavki cepiv
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
DE102004031550A1 (de) 2004-06-29 2006-02-02 Cognis Ip Management Gmbh Hochkonzentrierte, selbstemulgierende Emulsionsgrundlagen zur Herstellung von Öl in Wasser Emulsionen
GB0416120D0 (en) 2004-07-19 2004-08-18 Health Prot Agency Stable compositions containing OMV's
AU2005295777A1 (en) 2004-10-13 2006-04-27 3M Innovative Properties Company Method for preparing hydrophilic polyethersulfone membrane
TW200611880A (en) 2004-10-14 2006-04-16 Bi-Chang Li The microprocessor unit of bio-sludge-hydrolyzing equipment
KR101333923B1 (ko) 2004-11-09 2013-11-27 노바갈리 파르마 에스 에이 안정된 양성 제타 전위를 가지는 안과용 수중유 유제
GB0427568D0 (en) 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
US20090081253A1 (en) 2005-03-23 2009-03-26 Glaxosmithkline Biologicals S.A. Composition
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
WO2008051186A2 (en) 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
US8715739B2 (en) 2005-10-24 2014-05-06 Purdue Research Foundation Polymer coated microparticles
KR101211386B1 (ko) * 2005-11-04 2012-12-13 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. 알루미늄 보조제에 즉석 흡착되는 인플루엔자 백신
NZ567978A (en) 2005-11-04 2011-09-30 Novartis Vaccines & Diagnostic Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
WO2007098186A2 (en) 2006-02-22 2007-08-30 Novavax, Inc. Adjuvant and vaccine compositions
EP1849452A1 (de) * 2006-04-27 2007-10-31 Cognis IP Management GmbH Dispersionen, enthaltend Acylglutamate
PL2422810T3 (pl) 2006-07-17 2015-03-31 Glaxosmithkline Biologicals Sa Szczepionka przeciw grypie
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
EA200900784A1 (ru) 2006-12-06 2009-12-30 Новартис Аг Вакцины, включающие антиген из четырех штаммов вируса гриппа
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
KR20110009128A (ko) 2008-04-04 2011-01-27 로버트 쇼어 미세소관-상호작용 제제를 위한 지질-오일-물 나노에멀젼 전달 시스템
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
US8771746B2 (en) 2008-06-19 2014-07-08 Otonomy, Inc. Colloidal suspensions comprising a therapeutic agent and squalene
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
NZ600254A (en) 2009-12-03 2013-10-25 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
AU2010325748B2 (en) 2009-12-03 2014-04-17 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) * 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CL2012001399A1 (es) * 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
BR112012013427B8 (pt) 2009-12-03 2021-05-25 Novartis Ag circulação dos componentes durante a homogeneização de emulsões
WO2011106565A1 (en) 2010-02-24 2011-09-01 Travers William A Methods and devices for controlling particle size and particle size distribution
GB201009671D0 (en) * 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process

Also Published As

Publication number Publication date
SI2506834T1 (sl) 2016-04-29
EP2506834B1 (en) 2016-03-02
EP2356983B1 (en) 2013-02-20
SG10201501611QA (en) 2015-04-29
JP5820390B2 (ja) 2015-11-24
IL219984B (en) 2018-06-28
BR112012013427B8 (pt) 2021-05-25
PT2356983E (pt) 2013-04-23
CA2782511A1 (en) 2011-06-09
MX344381B (es) 2016-12-14
US20160113870A1 (en) 2016-04-28
US20160128937A1 (en) 2016-05-12
KR20120099750A (ko) 2012-09-11
SMT201300044B (it) 2013-07-09
HK1175404A1 (zh) 2013-07-05
EP2638895B1 (en) 2024-03-20
EP2638895A2 (en) 2013-09-18
EA201290426A1 (ru) 2012-11-30
US11141376B2 (en) 2021-10-12
MX2012006216A (es) 2012-07-12
SG181096A1 (en) 2012-07-30
WO2011067673A3 (en) 2012-05-10
CN102753149B (zh) 2015-10-14
EA024770B1 (ru) 2016-10-31
HRP20130398T1 (en) 2013-06-30
DK2356983T3 (da) 2013-03-11
KR101523215B1 (ko) 2015-05-27
US20130142833A1 (en) 2013-06-06
MX360299B (es) 2018-10-29
EP2506834A2 (en) 2012-10-10
AU2010325752B2 (en) 2013-12-19
AU2010325752A1 (en) 2012-06-21
ES2402569T3 (es) 2013-05-06
US10463615B2 (en) 2019-11-05
JP2015193656A (ja) 2015-11-05
CN102753149A (zh) 2012-10-24
JP2013512892A (ja) 2013-04-18
PL2356983T3 (pl) 2013-08-30
EP2356983A1 (en) 2011-08-17
CN105055311A (zh) 2015-11-18
US20180055769A1 (en) 2018-03-01
US8895629B2 (en) 2014-11-25
CA2782511C (en) 2013-11-12
EP2638895A3 (en) 2014-02-19
US20200268661A1 (en) 2020-08-27
NZ600323A (en) 2013-12-20
USRE46441E1 (en) 2017-06-20
IL219984A0 (en) 2012-07-31
WO2011067673A2 (en) 2011-06-09
ES2573710T3 (es) 2016-06-09
US9750690B2 (en) 2017-09-05
BR112012013427B1 (pt) 2021-03-30
SI2356983T1 (sl) 2013-05-31
RS52748B (en) 2013-08-30
BR112012013427A2 (pt) 2016-04-05

Similar Documents

Publication Publication Date Title
HK1160396A1 (en) Circulation of components during homogenization of emulsions
PT2222393E (pt) Processo para a preparação de emulsões de óleo em água a partir de concentrados de géis autoemulsificantes
EP2634711A3 (en) System and method for structural analysis
WO2012143603A3 (en) Methods and apparatuses for facilitating gesture recognition
PT2131181T (pt) Método para determinar o número de acidez total e o número de acidez nafténica de petróleo, cortes de petróleo e emulsões de petróleo do tipo água-em-óleo, por espectroscopia no infravermelho médio
MY159578A (en) Process for the preparation of an artificial latex
WO2014207562A3 (en) System, apparatus and method for formatting a manuscript automatically
WO2013002479A3 (ko) 나노에멀젼 조성물 및 그 제조방법
DK2817382T4 (da) Sammensætning omfattende en alkoxyleret aminforbindelse og en carboxylsyreforbindelse, anvendelse deraf i vand-i-olie emulsioner og fremgangsmåde til anvendelse af sammensætningen som eller som en del af en borevæske
IL249192A0 (en) Method and device for non-thermal treatment of nail, hand and foot fungus
FR2986962B1 (fr) Cupule pour implant orthopedique, implant orthopedique comprenant une telle cupule et procede pour realiser une telle cupule
JP2013027481A5 (zh)
CL2014001680A1 (es) Sistema para inhibir parasitos que infestan y/o se adhieren a animales acuaticos, que comprende una disposicion acuatica para generar una imagen acustica en una proximidad de la disposicion acustica dentro o en la proximidad de un ambiente acuatico acomodando dicho uno o mas animales acuaticos y/o parasitos, donde dicha disposicion acustica genera señales a frecuencias dentro de 9-100 hz; metodo y producto de software asociados.
MX340045B (es) Metodo y aparato para registro ocular multi-nivel.
EP2962728A4 (en) FIREPLACE COMPENSATION METHOD AND ULTRASONIC MEDICAL APPARATUS FOR THIS METHOD
AP2011005905A0 (en) Device and method for the verification and quantitative analysis of analytes, particularly mycotoxins.
BR112017021656A2 (pt) Método para promover a absorção lipídica pós- prandial e/ou aumentar a taxa de absorção lipídica pós-prandial em um indivíduo
EP3347844A4 (en) METHOD AND SYSTEM FOR DIAGNOSIS OF DISEASES AND FOR THE PREPARATION OF TREATMENT RECOMMENDATIONS
EP3567115A4 (en) BIOLOGICAL PROCESS FOR PREPARING HEMIC IRON NOT DERIVED FROM PORCINE BLOOD
EP2763376A3 (en) Method and device for providing service
EP3320851A4 (en) ULTRASONIC OBSERVATION DEVICE, ULTRASONIC OBSERVATION SYSTEM, OPERATING METHOD FOR ULTRASONIC OBSERVATION DEVICE AND OPERATING PROGRAM FOR ULTRASONIC OBSERVATION
WO2013070670A8 (en) Device for tendon and ligament treatment
EP3166329A4 (en) White noise generating headset for stress relaxation and concentration improvement, and white noise generating method using same
EP3526686A4 (en) METHOD AND SYSTEM FOR A DISTRIBUTION AND DISTRIBUTION PLATFORM OF ELECTRONIC STRUCTURED CONTENT
WO2012065180A3 (en) Method and apparatus for portable fluid delivery for animals